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Identity 
Other names: GAS 




The 4.3 kb gene for human gastrin contains two introns 
and 3 exons that encode preprogastrin, the gastrin 
precursor. It is located on chromosome 17(q21), and 
consists of three exons that contain the code sequence 
for a prepropeptide of 101 amino acid residues with a 
calculated molecular mass of 11.4 kDa (see diagram 
below). The primary structure of human preprogastrin 
protein consists of an N-terminal 21-amino acid signal 
sequence followed by a spacer peptide, a bioactive 
domain, and finally a hexapeptide C-terminal flanking 
peptide (CTFP). Upon initiation of translation, the 
signal sequence facilitates the translocation of the 
elongating polypeptide into the endoplasmic reticulum 
(ER), where it is subsequently removed by a 
membrane-bound signal peptidase that cleaves the 
growing polypeptide chain between alanine residue 21 
and serine 22 to generate the 80 amino acid peptide, 
progastrin. Progastrin is further processed (see protein 
section below) into the two principal C-terminal alpha-
amidated forms of circulating gastrin generated from 
the proteolytic cleavage of progastrin are gastrin-17 
(G17) and gastrin-34 (G34). 
Protein 
Note 
It should be noted that the numbering system of critical 
amino acid residues involved in peptide cleavage and 
post-translational modifications of gastrin varies within 
the scientific literature. This is due to the fact that the 
numbering system of some authors is based on the 
sequence of preprogastrin, which includes the 21 amino 
acids of the signal peptide sequence, whereas the 
numbering system of others is based on the sequence of 
progastrin. Our description of prohormone processing 
will be based on the 80 amino acid peptide sequence of 
progastrin. 
After signal peptide cleavage, progastrin undergoes 
additional post-translational modifications as it transits 
from the ER through the Golgi to the trans-Golgi 
network before it is sorted into immature secretory 
vesicles of the regulated exocytosis (secretory) 
pathway. The modifications include O-sulfation at 
tyrosine residue 66 of the propeptide by tyrosylprotein 
sulfotransferases and/or phosphorylation at serine 75 by 
a calcium-dependent casein-like kinase. Although O-
sulfation is thought to occur primarily in the trans-
Golgi network, a recent study provides evidence 
suggesting that it may continue through later 
compartments of the regulated secretory pathway. 
 
Chromosome 17 - NC_000017.10. 
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Schematic representation of the preprogastrin gene, its mRNA, and the peptide precursor preprogastrin. The gene is transcribed 
as a 303 nucleotide RNA transcript and the mRNA is processed into a 101 amino acid (aa) preprohormone. The preprogastrin peptide 
consists of a 21-aa signal sequence, which is co-translationally cleaved, a N-terminal spacer, the active peptide and the C-terminal 
flanking peptide (CTFP). Progastrin is formed after removal of the signal peptide. 
 
The extent of gastrin O-sulfation varies with species 
and cellular localization of peptide synthesis within the 
GI tract as well as the developmental stage of the 
tissues. For example, in adult humans, approximately 
half of the gastrin peptide synthesized in G cells of the 
antrum and duodenum, and released into the circulation 
are sulfated, whereas all of the gastrin peptide produced 
by the fetal pancreas appears to be sulfated. 
Functionally, sulfation of gastrin enhances 
endoproteolytic processing of progastrin, and may 
promote protein-protein interactions and peptide 
sorting between secretory pathways. However, unlike 
sulfation of the related peptide, cholecystokinin (CCK), 
sulfation of gastrin does not significantly affect its 
affinity for its physiologic receptor. 
Phosphorylation of serine 75 of progastrin may 
promote proteolytic processing at the upstream arginine 
residues at positions 73 and 74 (arginine 73-arginine 
74) releasing the C-terminal flanking peptide, and may 
affect the conversion of glycine-extended gastrin 
intermediates to mature C-terminal alpha-amidated 
peptides. However, since phosphorylation is not 
essential for progastrin processing, its biological 
significance remains an enigma. 
Following sulfation and/or phosphorylation, progastrin 
exits the trans-Golgi network and enters immature 
granules of the regulated secretory pathway. The major 
proteolytic processing of progastrin to its biologically 
active peptides occurs in the maturing dense core 
secretory granules of the regulated pathway. Progastrin 
is cleaved by two types of proteases: endo- and 
exopeptidases. Endopeptidases, also known as 
prohormone convertases (PC), typically cleave 
polypeptides downstream of two adjacent basic amino 
acid residues at the general motif (lysine/arginine)-
(X)n-(lysine/arginine), where n=0, 2, 4, or 6 and X is 
any amino acid, but usually not a Cysteine. PC1/3 and 
PC2 are involved in progastrin processing. 
The two principal biologically active forms of 
circulating gastrin are gastrin-17 (G17) and gastrin-34 
(G34). In rodent and human G cells of antrum and 
proximal duodenum, approximately 95% of the 
progastrin is processed to partially sulfated G17 (85%) 
and G34 (10%). Although G17 is the predominant 
product, G34 is the major circulating form of gastrin 
due to its slower rate of clearance. In both humans, the 
half-life of circulating G34 is approximately five times 
longer than that of G17. 
The proteolytic processing of progastrin involves 
convertase-specific cleavage at three dibasic consensus 
sites. PC1/3 is active early in the secretory pathway in 
granules with a neutral pH (i.e., pH ≈ 7) and cleaves the 
prohormone after the arginine 36-arginine 37 and 
arginine 73-arginine 74 sequences, releasing the C-
terminal flanking peptide, and generating G34. The 
post-cleavage residual basic residues are then removed 
by carboxypeptidase E, generating what are commonly 
referred to as the glycine-extended gastrins (i.e., G34-
Glycine). In contrast to PC1/3, PC2 is mainly active in 
mature granules at an acidic pH (i.e., pH ≈ 5). Cleavage 
of G34-glycine by PC2 after the dibasic amino acid 
sequence lysine 53-lysine 54 produces G17-glycine. 
These glycine-extended peptides are substrates for the 
peptidyl-glycine alpha-amidating monooxygenase 
(PAM) that utilizes the glycyl residue as an amide 
donor to alpha-amidate the carboxyl group of the C-
terminus of the peptide. The ratio of amidated gastrins 
to processing intermediates varies considerably across 
tissues and cell types. Processing intermediates are 
quite scarce in the gastric antrum, making up only 
about 1-5% of gastrin gene products, while in the 
duodenum the value has been reported to be as high  
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Processing of gastrin. The numbering system of critical amino acid residues involved in peptide cleavage and post-translational 
modifications of gastrin varies within the scientific literature. This is due to the fact that the numbering system of some authors is based 
on the sequence of preprogastrin, which includes the 21 amino acids of the signal peptide sequence, whereas the numbering system of 
others is based on the sequence of progastrin. The numbers at the top of the diagram represents the amino acid (aa) sequence for 
preprogastrin; the numbers at the bottom of the diagram represents the aa sequence for progastrin. The signal peptide is cleaved co-
translationally in the rough ER by signal peptidase. In the Trans-Golgi-Network (TGN), progastrin is modified by sulfation at Tyr 66 and 
phosphorylation of Ser 75 by a casein-like kinase. Prohormone convertases (PC) and carboxypeptidase E (CPE) sequentially convert the 
prohormone to the glycine-extended forms (G71-Gly, G34-Gly, G17-Gly). Abbreviations: CTFP: C-terminal flanking peptide, TPST: 
tyrosyl-protein sulfotransferase, PAM: peptidyl-alpha-amidating-monooxygenase. 
 
as 20%. Carboxyl-terminus alpha-amidation is a 
prerequisite for high affinity binding of gastrin to its 
cognate receptor, CCK2 receptor. 
Mutations 
Note 
There are no known mutations in the gastrin gene 
causing a pathologic entity. Overexpression of gastrin, 
or aberrant expression of gastrin, have both been 





Gastrinomas are neuroendocrine tumors that can arise 
from the stomach, duodenum or pancreas. Patients with 
multiple endocrine neoplasia type 1 (MEN1) have a 
mutation in the menin gene and are at very high risk for 
developing gastrinomas. In patients with 
hypergastrinemia due to pernicious anemia or MEN1, 
tissue and plasma levels of PAI-2 are elevated. Gastrin 
directly regulates PAI-2 expression in CCK2 receptor-
positive cells, and in neighboring receptor-negative 
cells, by way of paracrine mediators released from the 
CCK2 receptor-expressing cells. Direct regulation 
involves cell automous activation of CRE and AP-1 
transcription factors via a PKC, Ras, Raf, RhoA, and 
the NFkappaB signaling pathways in CCK2 receptor-
expressing cells by gastrin. The CRE and AP-1 
transcription factors, in turn, regulate expression of the 
genes for IL-8 and COX2. IL-8 acts through a 
GACAGA site via the activating signal cointegrator 1 
(ASC-1) complex, whereas prostaglandins, resulting 
from the activation of COX2, target the Myc-associated 
zinc finger protein (MAZ site via the small GTPase 




In a rat intestinal epithelial cell model, MAPKs mediate 
CCK2 receptor regulation of cyclooxgenase 2 (COX-2). 
COX-2 is an inducible enzyme catalyzing the rate-
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limiting step in prostaglandin synthesis, converting 
arachidonic acid to prostaglandin H2. A large body of 
genetic and biochemical evidence support the important 
role of COX-2 and the subsequent synthesis of 
prostaglandins in the regulation of inflammation and 
promotion of tumorigenesis. Gastrin has been shown to 




Gastric carcinogenesis is a multistep process that arises 
from superficial gastritis, chronic atrophic gastritis, 
progressing to intestinal metaplasia, dysplasia, and 
finally carcinoma. H. pylori is the most common 
known cause of chronic gastritis in humans, secretes 
urease, which converts urea to ammonia, and 
neutralizes the acid in the stomach. H. pylori initiates a 
host inflammatory response that is associated with the 
recruitment of mononuclear and polymorphonuclear 
leukocytes, and bone marrow-derived cells. Specific 
inflammatory cytokines from immune cells are required 
for the initiation and promotion of carcinogenesis. In 
addition to local inflammation, H. pylori induces the 
systemic elevation of serum gastrin (hypergastrinemia). 
The combination of achlorhydria and hypergastrinemia, 
induced by H. pylori infection, results in gastric 
bacterial overgrowth, lack of parietal cell 
differentiation, development of gastric metaplasia, and 
eventual progression to gastric carcinoma. 
Colorectal cancer 
Note 
Gastrin and gastrin-like peptides are upregulated 
locally in 78% of premalignant adenomatous polyps, 
before the appearance of invasive carcinoma, and 
gastrin expression has been linked to key mutations in 
the initiation of colorectal carcinogenesis. When the 
APCmin-/+ mouse was crossed with a gastrin gene 
knockout mouse, the hybrid developed fewer intestinal 
polyps. Gastrin transcription is linked to the Wnt/beta-
catenin pathway by a binding site for the transcription 
factor TCF4 in the gastrin promoter. Induction of the 
wild-type APC decreased gastrin mRNA expression, 
while transfection of constitutively active beta-catenin 
increased gastrin promoter activity. 
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